Abstract:We appreciate the comments of J. Elshof and co-workers on our article “High-flow nasal cannula for COVID-19 patients: low risk of bio-aerosol dispersion” [1] and agree that further research is warranted to reduce the risk of virus transmission from infected patients. The presented in vitro data of J. Elshof and co-workers from a model using light detection of smoke dispersion distance and velocity, suggesting that high-flow nasal cannula (HFNC) generates a larger dispersion distance than non-rebreather masks and Venturi masks, is in contrast to reports from Hui et al. [2] using a similar model. Presumably, because the smoke used by J. Elshof and co-workers was larger (0.3–2.5 µm) than that used by Hui et al. [2] (≤1 µm), the larger particles dispersed differently. It should be noted that smoke in both models represents only a small fraction of the range of bio-aerosols generated by patients during breathing, speaking, coughing or sneezing [3]. Using the same size airway model, J. Elshof and co-workers observed that the dispersion distance decreased from 71 cm to 25 cm by changing the nasal cannula size from small to large when HFNC flow was set at 30 L·min−1; however, when HFNC flow was set at 60 L·min−1, the medium-size nasal cannula generated a shorter distance than both small and large nasal cannulas. This raises the role of proper fit of prongs to nares and highlights the limitations of modelling. Regardless of the sizes of nasal cannula, the dispersion distance was farther with 60 L·min−1 than 30 L·min−1, which is in line with the results of Hui et al. [2] and may be expected, as higher velocity of the gas will carry exhaled smoke to a further distance. However, this effect of total flow did not occur when testing the Venturi mask. Surprisingly, the Venturi mask with large open holes and a total gas flow of 40 L·min−1 generated a shorter dispersion distance than normal breathing. These inconsistencies are difficult to interpret without comprehensive peer review of extensive methods and results. Whether smoke imaging models truly reflect the natural features of the transportation and dispersion of bio-aerosols generated by patients has not been established and results from these studies should be interpreted cautiously. High-flow nasal cannula does not generate higher risk of bio-aerosol dispersion than conventional oxygen masks https://bit.ly/2Yn0RQn

A Quantitative Study of Particle Dispersion due to Respiratory Support Modalities in PC-12 Aircraft: Prehospital Patient Transport

Quantification of aerosol dispersal from suspected aerosol-generating procedures

The Aerosol-Generating Effect Among Noninvasive Positive Pressure Ventilation, High-Flow Nasal Cannula, Nonrebreather Mask, Nasal Cannula, and Ventilator-Assisted Preoxygenation

In vitro model for investigating aerosol dispersion in a simulated COVID-19 patient during high-flow nasal cannula treatment

Reducing aerosol dispersion by high flow therapy in COVID‐19: High resolution computational fluid dynamics simulations of particle behavior during high velocity nasal insufflation with a simple surgical mask

Aerosol particle dispersion in spontaneous breathing training of oxygen delivery tracheostomized patients on prolonged mechanical ventilation

Variation in Aerosol Production Across Oxygen Delivery Devices in Spontaneously Breathing Human Subjects

Numerical and experimental study of aerosol dispersion in the Do728 aircraft cabin

Continuous aerosol monitoring and comparison of aerosol exposure based on smoke dispersion distance and concentrations during oxygenation therapy

High-flow nasal cannula for COVID-19 patients: risk of bio-aerosol dispersion

Practice Pattern Of Aerosol Therapy Among Patients Undergoing Mechanical Ventilation In Mainland China: A Web-Based Survey Involving 447 Hospitals

An in vitro study of the effects of respiratory circuit setup and parameters on aerosol delivery during mechanical ventilation

The Impact of Various High-Flow Nasal Cannula Devices on Transnasal Aerosol Delivery

Numerical Simulations of Interpersol Aerosol Transport in a Single-Aisle Aircraft Cabin

Assessment of aerosol persistence in ICUs via low-cost sensor network and zonal models

Effect of pressures and type of ventilation on aerosol delivery to chronic obstructive pulmonary disease patients

Effect of portable negative pressure units on expelled aerosols in the operating room environment

Aerosol Delivery Efficiency With High-Flow Nasal Cannula Therapy in Neonatal, Pediatric, and Adult Nasal Upper-Airway and Lung Models

Aerosol Generation During Nasal Airway Instrumentation

The utilization of aerosol therapy in mechanical ventilation patients: a prospective multicenter observational cohort study and a review of the current evidence

Aerosol release, distribution, and prevention during aerosol therapy: a simulated model for infection control